[在二碳酸的 flecainide 和 lacosamide 作用下,关键性心室内导电延迟的可逆性]
Anja Gallinger1, Rahman Osei-Davies2, F Hennersdorf3
1Klinik für Innere Medizin, Kardiologie und Angiologie, Schön Klinik Eilbek, Dehnhaide 120, 22081, Hamburg, Deutschland. agallinger@schoen-klinik.de.
Innere Medizin (Heidelberg, Germany)
|August 21, 2024
概括
一名72岁的患者因弗莱卡尼尼德和拉科萨米德联合治疗而出现昏迷. 碳酸输液逆转了心律失常效应,这表明对心脏通道的附加影响.
科学领域:
- 心脏病学 心脏病学
- 临床药理学 临床药理学
- 电子生理学 电子生理学
背景情况:
- 与弗莱卡尼德和拉科萨米德的联合治疗用于某些疾病.
- 药物诱导的心脏通道影响可能导致不良事件.
- 节律失常性需要及时的诊断和管理.
研究的目的:
- 为了呈现与联合弗莱卡尼尼德和拉科萨米德治疗有关的心律失常症的病例.
- 调查这些药物对心脏通道的潜在添加作用.
- 描述这种不良事件的成功管理.
主要方法:
- 一个72岁的女性患者的病例报告.
- 对药物组合疗法的分析 (弗莱卡尼德和拉科萨米德).
- 监测心电图变化 (QRS扩大,出口阻塞) 和对二碳酸输液的反应.
主要成果:
- 患者经历了心律失常性缩,QRS显著扩大和退出阻塞.
- 这些效应归因于弗莱卡因化和拉克索胺在心肌道上的附加作用.
- 需要暂时加快节奏,随着二碳酸的使用,症状完全逆转.
结论:
- 用弗莱卡尼德和拉科萨米德的联合治疗可以导致严重的心脏电生理学障碍.
- 碳酸作为一种有效的救助疗法,用于这种药物诱导的通道毒性.
- 这一案例强调了监测影响心脏通道的药物相互作用的重要性.
相关概念视频
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
940
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
940
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
800
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
800
01:30Cardiac Action Potential
1.2K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.2K
01:26Heart Failure Drugs: Inotropic Agents
547
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
547
01:19Depolarizing Blockers: Pharmocokinetics
316
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
316